Amrize (NYSE:AMRZ) Director Jacques Wolf Sanche Acquires 4,150 Shares of Stock

Amrize Ltd (NYSE:AMRZGet Free Report) Director Jacques Wolf Sanche purchased 4,150 shares of the business’s stock in a transaction on Wednesday, August 26th. The shares were bought at an average cost of $45.02 per share, for a total transaction of $186,833.00. Following the purchase, the director owned 9,766 shares of the company’s stock, valued at $439,665.32. This trade represents a 73.90% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which is available through this link.

Amrize Stock Up 1.2%

Shares of NYSE AMRZ opened at $44.77 on Thursday. Amrize Ltd has a 52-week low of $43.69 and a 52-week high of $65.94. The firm has a fifty day moving average of $49.94 and a 200-day moving average of $53.95. The stock has a market capitalization of $24.76 billion, a PE ratio of 20.63, a P/E/G ratio of 0.98 and a beta of 0.11. The company has a quick ratio of 0.73, a current ratio of 1.10 and a debt-to-equity ratio of 0.33.

Amrize (NYSE:AMRZGet Free Report) last issued its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). Amrize had a return on equity of 10.22% and a net margin of 9.89%.The firm had revenue of $3.49 billion during the quarter. On average, analysts anticipate that Amrize Ltd will post 2.74 EPS for the current year.

Amrize Announces Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were paid a $0.11 dividend. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is currently 20.28%.

Analysts Set New Price Targets

A number of analysts recently issued reports on AMRZ shares. Sanford C. Bernstein reissued an “outperform” rating on shares of Amrize in a research report on Monday, June 22nd. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of Amrize in a research report on Friday, June 26th. DA Davidson began coverage on shares of Amrize in a research note on Monday. They set a “neutral” rating and a $50.00 price objective for the company. Vertical Research raised shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price on the stock in a research note on Friday, May 1st. Finally, Wells Fargo & Company reduced their target price on shares of Amrize from $65.00 to $58.00 and set an “overweight” rating on the stock in a report on Wednesday, July 8th. One investment analyst has rated the stock with a Strong Buy rating, nine have assigned a Buy rating, six have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $59.87.

Read Our Latest Stock Analysis on AMRZ

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AMRZ. MCF Advisors LLC acquired a new position in shares of Amrize in the fourth quarter worth about $27,000. Basepoint Wealth LLC acquired a new position in shares of Amrize in the 4th quarter valued at about $33,000. Laurel Wealth Advisors LLC bought a new position in shares of Amrize during the fourth quarter valued at approximately $34,000. US Bancorp DE acquired a new stake in Amrize in the third quarter worth $38,000. Finally, Itau Unibanco Holding S.A. increased its holdings in shares of Amrize by 150.0% in the 4th quarter. Itau Unibanco Holding S.A. now owns 750 shares of the company’s stock worth $41,000 after acquiring an additional 450 shares during the period.

Amrize Company Profile

(Get Free Report)

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.

Further Reading

Insider Buying and Selling by Quarter for Amrize (NYSE:AMRZ)

Receive News & Ratings for Amrize Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amrize and related companies with MarketBeat.com's FREE daily email newsletter.